Derek Cole, Ph.D.

---

Dr. Cole, founder of Ferdia Therapeutics, has over 25 years of experience in pharmaceutical drug discovery. He previously led peptide therapeutic programs at RayzeBio and Takeda Pharmaceuticals, including gastric inhibitory peptide agonists now in Phase I clinical testing. Dr. Cole holds a B.S. in Chemistry from the University of Limerick, a Ph.D. in Synthetic Chemistry from the University of Alberta, and completed postdoctoral training in peptide drug discovery at Texas Tech University.